Fiscal 2023 Financial Guidance:
For the fiscal year ending May 31, 2023, Aehr is reiterating its previously provided guidance for total revenue to be at least $60 million to $70 million, representing growth of at least 18% to 38% year over year with strong profit margins similar to last fiscal year. Aehr also continues to expect bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade.
Management Conference Call and Webcast
Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its third quarter fiscal 2023 operating results. To access the live call, dial +1 877-270-2148 (US and Canada) or +1 412-902-6510 (International) and ask to join the Aehr Test Systems earnings call.
In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section and may also be accessed by clicking here. A replay of the conference call will also be available via telephone beginning approximately two hours after conclusion of the call and will remain available for one week. To access the call replay, dial +1 877-344-7529 (US and Canada) or +1 412-317-0088 (International) and enter replay passcode 2107882.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in semiconductor devices in wafer level, singulated die, and package part form, and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTS™ and FOX-P™ families of test and burn-in systems and FOX WaferPak™ Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge silicon carbide-based power semiconductors, memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a new low-cost single-wafer compact test and reliability verification solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The WaferPak Contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at www.aehr.com.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr’s future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates,” “going to,” "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," “sees,” or "continue," or the negative of these words or other similar terms or expressions that concern Aehr’s expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, Aehr’s ability to generate bookings and revenue increases in the future; future requirements and orders of Aehr’s new and existing customers; bookings forecasted for proprietary WaferPak™ and DiePak consumables across multiple market segments; the temporary nature of customer pushouts; shipping timelines for products and follow-on capacity orders; the growth of Aehr’s systems and consumables, including as a percentage of total sales; financial guidance for fiscal 2023, including related to revenue and profitability, and expectations regarding fiscal 2023; Aehr’s ability to expand its number of customers using its FOX-P™ solutions; the ability to secure potential customer engagements; and expectations related to long-term demand for Aehr’s productions and the attractiveness of key markets. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr’s recent 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
– Financial Tables to Follow –
AEHR TEST SYSTEMS AND SUBSIDIARIES | |||||||||||||||||||
Condensed Consolidated Statements of Operations | |||||||||||||||||||
(in thousands, except per share data) | |||||||||||||||||||
(unaudited) | |||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||
Feb 28, | Nov 30, | Feb 28, | Feb 28, | Feb 28, | |||||||||||||||
2023 | 2022 | 2022 | 2023 | 2022 | |||||||||||||||
Net sales | $ | 17,206 | $ | 14,815 | $ | 15,283 | $ | 42,692 | $ | 30,540 | |||||||||
Cost of sales | 8,331 | 6,904 | 8,886 | 21,425 | 17,343 | ||||||||||||||
Gross profit | 8,875 | 7,911 | 6,397 | 21,267 | 13,197 | ||||||||||||||
Operating expenses: | |||||||||||||||||||
Selling, general and administrative | 3,250 | 2,875 | 2,612 | 8,650 | 7,054 | ||||||||||||||
Research and development | 1,832 | 1,551 | 1,529 | 4,881 | 4,163 | ||||||||||||||
Total operating expenses | 5,082 | 4,426 | 4,141 | 13,531 | 11,217 | ||||||||||||||
Income from operations | 3,793 | 3,485 | 2,256 | 7,736 | 1,980 | ||||||||||||||
Interest income (expense), net | 374 | 263 | 1 | 758 | (9 | ) | |||||||||||||
Gain from forgiveness of PPP loan | - | - | - | - | 1,698 | ||||||||||||||
Other (expense) income, net | (18 | ) | (5 | ) | 10 | 1 | 68 | ||||||||||||
Income before income tax expense | 4,149 | 3,743 | 2,267 | 8,495 | 3,737 | ||||||||||||||
Income tax expense | (17 | ) | (18 | ) | (24 | ) | (49 | ) | (81 | ) | |||||||||
Net income | $ | 4,132 | $ | 3,725 | $ | 2,243 | $ | 8,446 | $ | 3,656 | |||||||||
Net income per share | |||||||||||||||||||
Basic | $ | 0.15 | $ | 0.14 | $ | 0.08 | $ | 0.31 | $ | 0.14 | |||||||||
Diluted | $ | 0.14 | $ | 0.13 | $ | 0.08 | $ | 0.29 | $ | 0.13 | |||||||||
Shares used in per share calculations: | |||||||||||||||||||
Basic | 27,893 | 27,579 | 26,871 | 27,571 | 25,684 | ||||||||||||||
Diluted | 29,373 | 29,080 | 28,854 | 29,080 | 27,510 |